Routine

Inpatient hyperglycaemia management

Diabetes · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Management of high glucose in hospitalised, non-critically-ill adults with diabetes. The aim is a SAFE glucose range using SCHEDULED insulin while avoiding hypoglycaemia — not tight control. (Acute DKA and HHS are managed on their own protocols.)

Red flags

  • Ketones positive / acidosis — this is DKA, change protocol
  • Recurrent hypoglycaemia — cut insulin, review timing against meals
  • Glucose persistently >20 mmol/L or rising despite correction — reassess regimen and precipitant

Assessment

Differential diagnosis

  • Diabetic ketoacidosis (exclude — check ketones)
  • Hyperosmolar hyperglycaemic state
  • Stress / steroid-induced hyperglycaemia
  • New-onset diabetes

Investigations

  • Capillary (point-of-care) glucose before meals & at bedtime
  • Blood/urine ketones if glucose high or unwell (exclude DKA)
  • U&E, HbA1c
  • Review every glucose-affecting drug (glucocorticoids, etc.)

Management

  • First exclude DKA / HHS (ketones, osmolality) — if present, switch to those protocols
  • Use a SCHEDULED basal–bolus regimen (basal + prandial + correction) — NOT correction-only “sliding-scale” insulin, which gives poor control and wide swings
  • Targets (non-critically ill): pre-meal <7.8 mmol/L (140 mg/dL), random <10 mmol/L (180 mg/dL); critically ill 7.8–10 mmol/L. Avoid glucose <3.9 mmol/L and avoid overly tight targets
  • If nil-by-mouth: CONTINUE basal insulin, HOLD prandial doses, use a correction scale, and consider a variable-rate IV insulin infusion for prolonged NBM / critical illness
  • Hold oral agents in the acutely unwell inpatient — metformin (contrast, AKI, lactic acidosis) and SGLT2 inhibitors (euglycaemic DKA risk when unwell / surgical / NBM)

Drugs & doses

Basal insulin (e.g. once-daily long-acting) — continue even when NBM
Prandial (rapid-acting) insulin with meals — hold if not eating
Correction-dose insulin for above-target readings — as an ADD-ON, never the sole therapy
Hypoglycaemia (<4 mmol/L): fast-acting carbohydrate or IV glucose, then recheck

Disposition

Inpatient diabetes team review; discharge with a clear written insulin plan and GP follow-up.

Complications & pitfalls

  • Hypoglycaemia (falls, aspiration, arrhythmia)
  • Progression to DKA / HHS
  • Impaired wound healing and infection
  • Rebound swings from sliding-scale-only regimens

Exam pearls

  • Scheduled basal–bolus beats sliding-scale-only insulin — the latter “chases” highs and causes swings and hypos
  • When NBM, keep the BASAL and drop the prandial — never stop ALL insulin in type 1 diabetes (ketosis)
  • Hold metformin and SGLT2 inhibitors in the acutely unwell / surgical inpatient (lactic acidosis; euglycaemic DKA)
  • A safe hospital target (7.8–10 mmol/L / 140–180 mg/dL) beats aggressive control — hypoglycaemia harms faster

Exclude DKA first; use scheduled insulin, not sliding-scale alone; never stop basal insulin in type 1.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.